GlassScriptPhysician profile
Andrew D Calhoun, SR.
NPI 1457422198
$1,241.81
in general payments reported to CMS, 2019-2025
12 companies · $66.63 in 2025
The $66.63 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $161 · 2021: $263 · 2022: $273 · 2024: $225 · 2025: $66.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $323.80 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $206.07 | 2019-2025 | Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $171.97 | 2021-2024 | Caplyta |
| Alkermes, INC. | $143.05 | 2019-2024 | Aristada, Lybalvi |
| Abbvie INC. | $106.73 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $89.32 | 2022-2024 | Ingrezza |
| Axsome Therapeutics, INC. | $61.22 | 2024 | Auvelity |
| Vanda Pharmaceuticals INC. | $57.60 | 2019-2024 | Fanapt |
| Indivior INC. | $33.17 | 2022-2024 | Sublocade |
| Otsuka America Pharmaceutical, INC. | $20.97 | 2020 | |
| Allergan, INC. | $14.79 | 2020 | |
| Lundbeck LLC | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Calhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.